aap Implantate AG
Develops, manufactures, and markets implants for the treatment of bone fractures.
AAQ1 | F
Overview
Corporate Details
- ISIN(s):
- DE000A32VP65 (+4 more)
- LEI:
- 39120001TRQTQ01LPP57
- Country:
- Germany
- Address:
- Lorenzweg 5, 12099 Berlin
- Website:
- https://www.aap.de/
- Sector:
- Manufacturing
Description
aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-19 07:30 |
aap successfully places a 10% capital increase from authorized capital at EUR 1…
|
English | 9.1 KB | ||
| 2024-04-17 18:57 |
aap Implantate AG: aap postpones publication of the consolidated financial stat…
|
English | 9.8 KB | ||
| 2024-04-03 17:35 |
aap 100% approval of the proposed resolution to amend the terms and conditions …
|
English | 8.9 KB | ||
| 2024-03-18 12:35 |
aap Implantate AG: Capital increase from authorized capital with exclusion of s…
|
English | 9.5 KB | ||
| 2024-03-05 12:18 |
aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an …
|
English | 9.7 KB | ||
| 2024-02-15 13:04 |
After a mixed 2023 financial year, aap makes a strong start to the 2024 financi…
|
English | 12.6 KB | ||
| 2024-01-10 07:30 |
More than 100 patients included in the human clinical trial by 31 December 2023…
|
English | 10.3 KB | ||
| 2024-01-09 07:30 |
aap concludes distribution agreement for LOQTEQ VA Radius System with leading g…
|
English | 9.2 KB | ||
| 2023-12-21 12:46 |
Adjustment of the forecast for revenue and EBITDA for FY 2023; implementation o…
|
English | 10.2 KB | ||
| 2023-10-30 11:44 |
Visible acceleration in clinical trial with already more than 60 patients; incr…
|
English | 11.5 KB | ||
| 2023-10-06 12:30 |
aap Implantate AG: Deepblue Holding AG, Subscription of partial bonds in the co…
|
English | 8.2 KB | ||
| 2023-10-05 15:00 |
aap Implantate AG: Deepblue Holding AG, Exercise of subscription rights in the …
|
English | 8.0 KB | ||
| 2023-10-04 19:58 |
aap places mandatory convertible bond 2023/2028 in the amount of EUR 2.5 million
|
English | 9.3 KB | ||
| 2023-09-19 12:00 |
aap Implantate AG: Marek Hahn, Granting of 47,364 subscription rights as part o…
|
English | 7.7 KB | ||
| 2023-09-08 16:06 |
aap offers its shareholders a EUR 2.7 million mandatory convertible bond; subsc…
|
English | 11.7 KB |
Automate Your Workflow. Get a real-time feed of all aap Implantate AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for aap Implantate AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for aap Implantate AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-15 | di Girolamo, Rubino | Board | Buy | None | 990.00 EUR |
| 2023-03-30 | Deepblue Holding AG | Close relation | Other | None | 249,999.40 EUR |
| 2023-03-30 | Merval AG | Close relation | Other | None | 140,000.00 EUR |
| 2023-03-30 | di Girolamo, Rubino | Board | Other | None | 83,743.80 EUR |
| 2023-03-30 | Hahn, Marek | Board | Other | None | 52,920.00 EUR |
| 2023-03-30 | Mierzejewska, Agnieszka | Board | Other | None | 26,800.20 EUR |
| 2022-02-03 | Merval AG | Close relation | Other | None | 650,000.47 EUR |
| 2021-10-28 | Active Ownership Fund SICAV-FIS SCS | Close relation | Other | None | 60,792,157.00 EUR |
| 2021-10-27 | Merval AG | Close relation | Other | None | 318,324.60 EUR |
| 2021-10-27 | Visser, Biense | Supervisory board | Other | None | 3,573.90 EUR |
Peer Companies
